Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

PathGroup chooses Proscia for digital pathology

By Author Proscia | March 1, 2023

U.S. pathology services provider PathGroup is expanding its operations with Proscia’s digital pathology software platform Concentriq Dx.

PathGroup supports more than 15,000 referring physicians and more than 200 hospital customers with diversified laboratory testing services and customer service.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency. 

Our website uses cookies. By using this site, you agree to its use of cookies.